Australian State Reports Return Of H1N1 Flu, Urges First Shots
This article was originally published in PharmAsia News
Executive SummarySouth Australia reports a return of the H1N1 flu, the basis of the global flu pandemic
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.